Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox

被引:33
|
作者
Koonin, Eugene V. [2 ]
Gootenberg, Jonathan S. [1 ]
Abudayyeh, Omar O. [1 ]
机构
[1] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA
[2] Natl Ctr Biotechnol Informat, Natl Lib Med, NIH, Bethesda, MD 20894 USA
基金
美国国家卫生研究院;
关键词
ALTERED PAM SPECIFICITIES; RNA-GUIDED ENDONUCLEASE; NUCLEIC-ACID DETECTION; IN-VIVO; STRUCTURAL BASIS; EVOLUTIONARY CLASSIFICATION; DETECTION PLATFORM; PROTEIN CLEAVAGE; TARGETING RANGE; DENGUE VIRUS;
D O I
10.1021/acs.biochem.3c00159
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CRISPRsystems mediate adaptive immunity in bacteria and archaeathrough diverse effector mechanisms and have been repurposed for versatileapplications in therapeutics and diagnostics thanks to their facilereprogramming with RNA guides. RNA-guided CRISPR-Cas targeting andinterference are mediated by effectors that are either componentsof multisubunit complexes in class 1 systems or multidomain single-effectorproteins in class 2. The compact class 2 CRISPR systems have beenbroadly adopted for multiple applications, especially genome editing,leading to a transformation of the molecular biology and biotechnologytoolkit. The diversity of class 2 effector enzymes, initially limitedto the Cas9 nuclease, was substantially expanded via computationalgenome and metagenome mining to include numerous variants of Cas12and Cas13, providing substrates for the development of versatile,orthogonal molecular tools. Characterization of these diverse CRISPReffectors uncovered many new features, including distinct protospaceradjacent motifs (PAMs) that expand the targeting space, improved editingspecificity, RNA rather than DNA targeting, smaller crRNAs, staggeredand blunt end cuts, miniature enzymes, promiscuous RNA and DNA cleavage,etc. These unique properties enabled multiple applications, such asharnessing the promiscuous RNase activity of the type VI effector,Cas13, for supersensitive nucleic acid detection. class 1 CRISPR systemshave been adopted for genome editing, as well, despite the challengeof expressing and delivering the multiprotein class 1 effectors. Therich diversity of CRISPR enzymes led to rapid maturation of the genomeediting toolbox, with capabilities such as gene knockout, base editing,prime editing, gene insertion, DNA imaging, epigenetic modulation,transcriptional modulation, and RNA editing. Combined with rationaldesign and engineering of the effector proteins and associated RNAs,the natural diversity of CRISPR and related bacterial RNA-guided systemsprovides a vast resource for expanding the repertoire of tools formolecular biology and biotechnology.
引用
收藏
页码:3465 / 3487
页数:23
相关论文
共 50 条
  • [31] Chemical engineering of CRISPR-Cas systems for therapeutic application
    Barber, Halle M.
    Pater, Adrian A.
    Gagnon, Keith T.
    Damha, Masad J.
    O'Reilly, Daniel
    NATURE REVIEWS DRUG DISCOVERY, 2024,
  • [32] Engineering virus resistance via CRISPR-Cas systems
    Mahas, Ahmed
    Mahfouz, Magdy
    CURRENT OPINION IN VIROLOGY, 2018, 32 : 1 - 8
  • [33] Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
    Mohanraju, Prarthana
    Makarova, Kira S.
    Zetsche, Bernd
    Zhang, Feng
    Koonin, Eugene V.
    van der Oost, John
    SCIENCE, 2016, 353 (6299)
  • [34] CRISPRdisco: An Automated Pipeline for the Discovery and Analysis of CRISPR-Cas Systems
    Crawley, Alexandra R.
    Henriksan, Jams R.
    Barranaou, Rodolphe
    CRISPR JOURNAL, 2018, 1 (02): : 171 - 181
  • [35] CRISPR-Cas Genome Surgery in Ophthalmology
    DiCarlo, James E.
    Sengillo, Jesse D.
    Justus, Sally
    Cabral, Thiago
    Tsang, Stephen H.
    Mahajan, Vinit B.
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2017, 6 (03):
  • [36] An introduction to CRISPR-Cas systems for reprogramming the genome of mammalian cells
    Singh, Vijai
    REPROGRAMMING THE GENOME: CRISPR-CAS-BASED HUMAN DISEASE THERAPY, 2021, 181 : 1 - 13
  • [37] Exploiting CRISPR-Cas immune systems for genome editing in bacteria
    Barrangou, Rodolphe
    van Pijkeren, Jan-Peter
    CURRENT OPINION IN BIOTECHNOLOGY, 2016, 37 : 61 - 68
  • [38] The CRISPR-Cas toolbox for analytical and diagnostic assay development
    Tang, Yanan
    Gao, Lu
    Feng, Wei
    Guo, Chen
    Yang, Qianfan
    Li, Feng
    Le, X. Chris
    CHEMICAL SOCIETY REVIEWS, 2021, 50 (21) : 11844 - 11869
  • [39] Recent advancements in CRISPR-Cas toolbox for imaging applications
    Singh, Vikram
    Jain, Mukesh
    CRITICAL REVIEWS IN BIOTECHNOLOGY, 2022, 42 (04) : 508 - 531
  • [40] CRISPR-Cas systems: ushering in the new genome editing era
    Rojo, Fernando Perez
    Nyman, Rikard Karl Martin
    Johnson, Alexander Arthur Theodore
    Navarro, Maria Pazos
    Ryan, Megan Helen
    Erskine, William
    Kaur, Parwinder
    BIOENGINEERED, 2018, 9 (01) : 214 - 221